140 - Mike Uchrin, CEO & Co-Founder, Monogram Health – The Innovative Start-Up that’s Disrupting Kidney Care

A Second Opinion with Senator Bill Frist, M.D.

コンテンツは Bill Frist and A Second Opinion Podcast によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャストコンテンツは、Bill Frist and A Second Opinion Podcast またはそのポッドキャストプラットフォームパートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。

2+ y ago 1:00:42

MP3•エピソードのホーム

アーカイブされたシリーズ ("無効なフィード" status)

When? This feed was archived on August 02, 2023 17:10 (9M ago). Last successful fetch was on June 27, 2023 13:36 (10M ago)

Why? 無効なフィード status. サーバーは持続期間に有効なポッドキャストのフィードを取得することができませんでした。

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Mike Uchrin is the CEO & Co-Founder of Monogram Health, an innovative, exciting new company that’s transforming one of the most complex and underserved areas of healthcare: managing chronic kidney disease and end-stage renal disease. Based in Nashville, Tennessee, Monogram partners with health plans to fill a systemic gap in kidney disease care with a new, in-home, evidence-based model that improves patient outcomes and quality of life while dramatically reducing costs for the health care system.

One in 7 adults suffer from chronic kidney disease and ESRD, and the cost of covering people with kidney disease represents 20% — or $114 billion — of traditional Medicare expenditures. In our discussion today, Mike shares how Monogram is creatively and proactively addressing this national care challenge.

201 つのエピソード